Table of Contents

company-logo

China Biotech Services Holdings Limited, an investment holding company, provides medical laboratory testing and health check services in the People's Republic of China and Hong Kong. The company operates through five segments: Immunotherapy, Pharmaceutical Products, Medical and Health Related Services, Securities, Insurance brokerage, and Others segments. It also engages in the research, development, manufacture, sale, and distribution of health related and pharmaceutical products; trading of securities; money lending business; provision of tumor immune cell therapy, immune cell storage, and health management services; and provision of coordination of healthcare providers services. In addition, the company markets and sells health supplements, slimming pills, Chinese medicines, and beauty products; trades in pharmaceutical intermediates; and offers insurance brokerage services. Further, it provides property investment and logistic services. The company was formerly known as Rui Kang Pharmaceutical Group Investments Limited and changed its name to China Biotech Services Holdings Limited in November 2017. China Biotech Services Holdings Limited was founded in 1996 and is headquartered in Causeway Bay, Hong Kong.

China Biotech Services Dividend Announcement

• China Biotech Services announced a annually dividend of HK$0.01 per ordinary share which will be made payable on 2023-06-15. Ex dividend date: 2023-05-19
• China Biotech Services annual dividend for 2023 was HK$0.01
• China Biotech Services's trailing twelve-month (TTM) dividend yield is -%

China Biotech Services Dividend History

Ex-Div dateDividend amountDividend typePay date
2023-05-19HK$0.01annually2023-06-15
2004-08-19HK$0.01annually2004-09-30

China Biotech Services Dividend per year

China Biotech Services Dividend Yield

China Biotech Services current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing China Biotech Services stock? Use our calculator to estimate your expected dividend yield:

China Biotech Services Financial Ratios

P/E ratio-2.35
PEG ratio-0.23
P/B ratio1.09
ROE-37.97%
Payout ratio0.00%
Current ratio0.74
Quick ratio0.72
Cash Ratio0.16

China Biotech Services Dividend FAQ

Does China Biotech Services stock pay dividends?
China Biotech Services does not currently pay dividends to its shareholders.
Has China Biotech Services ever paid a dividend?
No, China Biotech Services has no a history of paying dividends to its shareholders. China Biotech Services is not known for its dividend payments.
Why doesn't China Biotech Services pay dividends?
There are several potential reasons why China Biotech Services would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will China Biotech Services ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While China Biotech Services has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is China Biotech Services a dividend aristocrat?
China Biotech Services is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is China Biotech Services a dividend king?
China Biotech Services is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is China Biotech Services a dividend stock?
No, China Biotech Services is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy China Biotech Services stocks?
To buy China Biotech Services you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy China Biotech Services stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.